Sitagliptin Metformin XR Spirig HC 50/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung - 160 Swissmedic Key 69160004 Registration Holder Spirig HealthCare AG Name Sitagliptin Metformin XR Spirig HC 50/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung Date of registration 03.08.2023 Original/Generic Generic Introduction of Sequence 03.08.2023 ATC-Classification Metformin and Sitagliptin (A10BD07) Revision date WHO WHO-DDD Valid until 02.08.2028 Index Therapeuticus (BSV) 07.06.20. Show package size 160 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 40.31 Limitation Yes Limitation text
Deductible 10 % Consumer price 60.25 Feedback FB GTIN 7680691600043 Medication Code Synthetika Pharmacode Disponibility
Composition metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, pro compresso, natrium 2.1 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Metformin Hydrochloride 1000 mg Sitagliptine 50 mg
BAG: Active Agent Dose Metformin Hydrochloride 1000 mg Sitagliptine 50 mg
Inactive agents Dose additional_information Calcium Hydrogen Phosphate Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Macrogol 4000 Magnesii Stearas Natrii Stearylis Fumaras Sodium 2.1 mg Poly(Alcohol Vinylicus) Überzug Pro Compresso Talcum
Source Data was imported : 07.10.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
